Valuation: Instituto Rosenbusch S.A.

Market Cap 5.79B 3.75M 3.35M 3.07M 2.79M 5.24M 355M 5.38M 36.7M 14.76M 187M 14.06M 13.76M 594M P/E 2024
-3.67x
P/E 2025 -2.23x
Enterprise Value 6.53B 4.22M 3.77M 3.47M 3.15M 5.91M 400M 6.06M 41.37M 16.64M 211M 15.85M 15.51M 669M EV / Sales 2024
0.73x
EV / Sales 2025 1.71x
Free-Float
19.84%
Yield 2024 *
-
Yield 2025 -
1 day-1.81%
1 week+0.37%
Current month-1.81%
1 month-3.20%
3 months-14.73%
6 months-17.58%
Current year-43.45%
1 week 130
Extreme 130
144
1 month 130
Extreme 130
154
Current year 128.5
Extreme 128.5
260
1 year 128.5
Extreme 128.5
357
3 years 46
Extreme 46
450
5 years 9.1
Extreme 9.1
450
10 years 4.2
Extreme 4.2
450
Manager TitleAgeSince
Director of Finance/CFO - 30/07/2010
Chief Tech/Sci/R&D Officer - -
Chief Administrative Officer - -
Director TitleAgeSince
Chairman - 30/07/2010
Change 5-day change 1-year change 3-year change Capi.($)
-1.81%+0.37%-15.53%+183.92% 3.75M
-0.30%+10.02%+57.32%+148.40% 1,257B
-1.88%-0.78%+43.15%+76.18% 651B
-1.27%-0.07%+35.02%+102.37% 510B
-1.56%-2.01%+50.67%+64.81% 388B
-3.25%+1.28%+74.12%+38.93% 366B
-0.02%+2.11%+32.16%+57.79% 303B
-0.72%+7.32%+11.29%+33.98% 288B
-0.99%+3.34%+56.24%+71.54% 252B
-1.19%+6.26%+38.50%+107.18% 211B
Average -1.25%+4.10%+38.29%+88.51% 422.67B
Weighted average by Cap. -1.09%+5.30%+47.34%+93.62%

Financials

2024 2025
Net sales 8.27B 5.35M 4.78M 4.39M 3.99M 7.49M 507M 7.68M 52.43M 21.09M 268M 20.09M 19.66M 848M 6.4B 4.14M 3.7M 3.4M 3.09M 5.8M 392M 5.94M 40.57M 16.32M 207M 15.55M 15.21M 656M
Net income -1.42B -917K -819K -752K -683K -1.28M -86.84M -1.32M -8.98M -3.61M -45.83M -3.44M -3.37M -145M -4.6B -2.97M -2.66M -2.44M -2.22M -4.16M -282M -4.27M -29.13M -11.72M -149M -11.16M -10.92M -471M
Net Debt 863M 558K 499K 458K 416K 781K 52.89M 801K 5.47M 2.2M 27.91M 2.1M 2.05M 88.47M 738M 477K 426K 392K 356K 668K 45.2M 685K 4.67M 1.88M 23.86M 1.79M 1.75M 75.62M
Projected Income Statement - Annual - Instituto Rosenbusch S.A.
Logo Instituto Rosenbusch S.A.
Instituto Rosenbusch SA de Biologia Experimental Agropecuaria is an Argentina-based company primarily engaged in the production and sale of such veterinary products as antiparasitic drugs, vitamins, hormone treatments and vaccines, among others. The Company's products are structured in two lines: Pharmaceutical, including antibiotics, antimastitics products, antimycotics, antiparasites, vitamins, minerals and other chemotherapies, and Biological, comprising vaccines for cattle, equines, porks and sheeps and dogs. It is also involved in the slaughtering and provision of meat products. As of December 31, 2011, the Company owned such subsidiaries as Laboratorios Rosenbusch SA, Laboratorios Bolivar SA and Rosenbusch Paraguay SA.
Employees
-
Date Price Change Volume
02/11/26 ARS 136.00 -1.81% 3,263
30/10/26 ARS 138.50 -0.72% 10,354
29/10/26 ARS 139.50 +2.57% 1,200
28/10/26 ARS 136.00 -0.37% 10,969
27/10/26 ARS 136.50 +0.74% 17,143
  1. Stock Market
  2. Stocks
  3. ROSE Stock